KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Dec 2024 value amounting to $15.0 billion.

  • Regeneron Pharmaceuticals' Change in Acquisitions & Divestments fell 20.98% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 21.95%. This contributed to the annual value of $15.0 billion for FY2024, which is 59.15% up from last year.
  • According to the latest figures from FY2024, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments is $15.0 billion, which was up 59.15% from $9.4 billion recorded in FY2023.
  • Over the past 5 years, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments peaked at $15.0 billion during FY2024, and registered a low of $2.2 billion during FY2021.
  • Over the past 3 years, Regeneron Pharmaceuticals' median Change in Acquisitions & Divestments value was $9.4 billion (recorded in 2023), while the average stood at $10.0 billion.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 41.47% in 2021, and later spiked by 150.55% in 2022.
  • Over the past 5 years, Regeneron Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $3.8 billion in 2020, then slumped by 41.47% to $2.2 billion in 2021, then soared by 150.55% to $5.6 billion in 2022, then skyrocketed by 70.11% to $9.4 billion in 2023, then skyrocketed by 59.15% to $15.0 billion in 2024.